Pectin/Alginate bio-nanocomposite hydrogel beads based on in-situ formed layered double hydroxide in the presence of Mentha extract: Antibacterial carrier for potential pH-responsive targeted anti-cancer drug delivery
{"title":"Pectin/Alginate bio-nanocomposite hydrogel beads based on in-situ formed layered double hydroxide in the presence of Mentha extract: Antibacterial carrier for potential pH-responsive targeted anti-cancer drug delivery","authors":"Roghayeh Fathi, Siamak Javanbakht, Reza Mohammadi","doi":"10.1016/j.eurpolymj.2024.113548","DOIUrl":null,"url":null,"abstract":"<div><div>This research presents the creation of novel pH-responsive drug delivery carriers with potential applications in cancer treatment. The study involved the Mentha Extract (ME) for the in-situ synthesis of Layered Double Hydroxide (LDH) bio nanoparticles (LDH-ME NPs). These NPs were incorporated into a biopolymeric hybrid formulation containing Pectin and Alginate to produce bio-nanocomposite hydrogel beads. The morphology and chemical composition were assessed and confirmed through various techniques. Doxorubicin (DOX) was employed as a representative anti-cancer medication to investigate the controlled drug release properties of the newly developed hydrogel beads (loading capacity: ∼92 %). <em>In vitro</em> experiments revealed that the drug release pattern was significantly regulated in response to pH levels (with a higher drug release rate at pH 7.4, about 89 %). The assessment for antibacterial properties validated the effective antibacterial performance of the hydrogel beads toward <em>S. aureus</em> and <em>E. coli</em> with inhibition zones about 20 mm and 14 mm, respectively. MTT assay indicated a high level of cytocompatibility with HT-29 cells (cell viability exceeding 95 %) for the blank bio-nanocomposite hydrogel beads. Conversely, bio-nanocomposite hydrogel beads loaded with DOX exhibited notable cytotoxicity (∼13 % cell viability in 15.6 µg/mL) against HT-29 cells. These findings recommend the current bio-nanocomposite as a promising bio-platform with superior antibacterial and anti-cancer properties.</div></div>","PeriodicalId":315,"journal":{"name":"European Polymer Journal","volume":"221 ","pages":"Article 113548"},"PeriodicalIF":5.8000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Polymer Journal","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014305724008097","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"POLYMER SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
This research presents the creation of novel pH-responsive drug delivery carriers with potential applications in cancer treatment. The study involved the Mentha Extract (ME) for the in-situ synthesis of Layered Double Hydroxide (LDH) bio nanoparticles (LDH-ME NPs). These NPs were incorporated into a biopolymeric hybrid formulation containing Pectin and Alginate to produce bio-nanocomposite hydrogel beads. The morphology and chemical composition were assessed and confirmed through various techniques. Doxorubicin (DOX) was employed as a representative anti-cancer medication to investigate the controlled drug release properties of the newly developed hydrogel beads (loading capacity: ∼92 %). In vitro experiments revealed that the drug release pattern was significantly regulated in response to pH levels (with a higher drug release rate at pH 7.4, about 89 %). The assessment for antibacterial properties validated the effective antibacterial performance of the hydrogel beads toward S. aureus and E. coli with inhibition zones about 20 mm and 14 mm, respectively. MTT assay indicated a high level of cytocompatibility with HT-29 cells (cell viability exceeding 95 %) for the blank bio-nanocomposite hydrogel beads. Conversely, bio-nanocomposite hydrogel beads loaded with DOX exhibited notable cytotoxicity (∼13 % cell viability in 15.6 µg/mL) against HT-29 cells. These findings recommend the current bio-nanocomposite as a promising bio-platform with superior antibacterial and anti-cancer properties.
期刊介绍:
European Polymer Journal is dedicated to publishing work on fundamental and applied polymer chemistry and macromolecular materials. The journal covers all aspects of polymer synthesis, including polymerization mechanisms and chemical functional transformations, with a focus on novel polymers and the relationships between molecular structure and polymer properties. In addition, we welcome submissions on bio-based or renewable polymers, stimuli-responsive systems and polymer bio-hybrids. European Polymer Journal also publishes research on the biomedical application of polymers, including drug delivery and regenerative medicine. The main scope is covered but not limited to the following core research areas:
Polymer synthesis and functionalization
• Novel synthetic routes for polymerization, functional modification, controlled/living polymerization and precision polymers.
Stimuli-responsive polymers
• Including shape memory and self-healing polymers.
Supramolecular polymers and self-assembly
• Molecular recognition and higher order polymer structures.
Renewable and sustainable polymers
• Bio-based, biodegradable and anti-microbial polymers and polymeric bio-nanocomposites.
Polymers at interfaces and surfaces
• Chemistry and engineering of surfaces with biological relevance, including patterning, antifouling polymers and polymers for membrane applications.
Biomedical applications and nanomedicine
• Polymers for regenerative medicine, drug delivery molecular release and gene therapy
The scope of European Polymer Journal no longer includes Polymer Physics.